Synthetic HIV-1 Matrix Protein P17-Based AT20-KLH Therapeutic Immunization in HIV-1-infected Patients Receiving Antiretroviral Treatment: A Phase I Safety and Immunogenicity Study
BMC Infectious Diseases - United Kingdom
doi 10.1186/1471-2334-14-s2-o6
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 1, 2014
Authors
Publisher
Springer Science and Business Media LLC